TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial October 13, 1995
TCL Archive High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial November 28, 2008
TCL Archive Robert Young To Step Down As Fox Chase Cancer Center President in 2007. September 29, 2006
TCL Archive Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction September 19, 1975